Drug Type siRNA |
Synonyms oligonucleotide-SPG complex, NJA 730, NJA-730A + [1] |
Target |
Action inhibitors |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors), Immunosuppressants, RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft vs Host Disease | Phase 1 | Australia | 04 Nov 2018 |